Physician profile
Michael H Rock
NPI 1760596886
$6,801.66
in general payments reported to CMS, 2019-2025
20 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,547 · 2020: $3,262 · 2021: $263 · 2022: $103 · 2023: $56.33 · 2024: $327 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184 · Travel and Lodging: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.38 |
| Travel and Lodging | $442.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,031.78 | 2019-2025 | Proclaim |
| Nalu Medical, INC. | $632.50 | 2020 | |
| Biotronik Nro, INC. | $605.34 | 2024-2025 | Prospera |
| Spinefrontier, INC. | $537.84 | 2025 | Nanofuse, Facetfuse, Sijfuse |
| Nevro Corp. | $227.06 | 2019-2024 | Senza |
| Si-Bone, INC. | $217.29 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $210.78 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $172.92 | 2019-2020 | |
| Medtronic USA, INC. | $157.21 | 2020 | |
| Medtronic, INC. | $155.15 | 2021-2024 | Intellis Adaptivestim |
| Sentynl Therapeutics, INC. | $152.15 | 2019-2020 | |
| Boston Scientific Corporation | $145.72 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $141.94 | 2019-2020 | |
| Pfizer INC. | $115.55 | 2019-2020 | |
| Tersera Therapeutics LLC | $89.41 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $68.50 | 2019 | |
| Vertiflex, INC. | $68.29 | 2019 | |
| Vertical Pharmaceuticals, LLC | $39.43 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.51 | 2019 | |
| Daiichi Sankyo INC. | $15.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.